Quantitative analysis of diabetic macular ischemia using optical coherence tomography

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 1, 2014, Pages 417-423

  Sim, Dawn A ^a,b   Keane, Pearse A ^a,b   Fung, Simon ^a   Karampelas, Michael ^b   Sadda, Srinivas R ^c   Fruttiger, Marcus ^b   Patel, Praveen J ^a,b   Tufail, Adnan ^a,b   Egan, Catherine A ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Fluorescein angiography; Ischemia; Maculopathy; Optical coherence tomography; Visual acuity

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DIABETIC MACULAR ISCHEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOVEAL AVASCULAR ZONE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULOPATHY; RETINAL NERVE FIBER LAYER THICKNESS; SUBFOVEAL CHOROIDAL THICKNESS; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

DIABETES MELLITUS; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; ISCHEMIA; MACULOPATHY; OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84896727882     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12677     Document Type: Article

References (50)

1. Arend O, Wolf S, Jung F, et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75:514-518.
2. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. 2000; 77(suppl):S113-S119.
3. Grant MB, Afzal A, Spoerri P, et al. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs. 2004;13:1275-1293.
4. Arend O, Wolf S, Harris A, Reim M. The relationship of macular microcirculation to visual acuity in diabetic patients. Arch Ophthalmol. 1995;113:610-614.
5. Sim DA, Keane PA, Zarranz-Ventura J, et al. The effects of macular ischemia on visual acuity in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:2353-2360.
6. Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol. 1970;69:403-414.
7. Bresnick GH, Engerman R, Davis MD, et al. Patterns of ischemia in diabetic retinopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;814(pt 1):OP694-OP709.
8. Bresnick GH, De Venecia G, Myers FL, et al. Retinal ischemia in diabetic retinopathy. Arch Ophthalmol. 1975;93:1300-1310. 9.
9. Byeon SH, Chu YK, Lee H, et al. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. Ophthalmology. 2009;116:1949-1959.
10. Lee DH, Kim JT, Jung DW, et al. The relationship between foveal ischemia and spectral-domain optical coherence tomography findings in ischemic diabetic macular edema. Invest Ophthalmol Vis Sci. 2013;54:1080-1085.
11. Reznicek L, Kernt M, Haritoglou C, et al. In vivo characterization of ischemic retina in diabetic retinopathy. Clin Ophthalmol. 2010;5:31-35.
12. Alasil T, Keane PA, Updike JF, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology. 2010;117: 2379-2386.
13. Keane PA, Heussen FM, Ouyang Y, et al. Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53:1152-1161.
14. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496-500.
15. Sim DA, Keane PA, Mehta H, et al. Repeatability and reproducibility of choroidal vessel layer measurements in diabetic retinopathy using enhanced depth optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:2893-2901.
16. Mackenzie S, Schmermer C, Charnley A, et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PLoS One. 2011;6:e14811.
17. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 suppl):807-822.
18. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thicknessmeasurements obtained by optical coherence tomography. Ophthalmology. 2006;113:285-293.
19. Sadda SR, Joeres S, Wu Z, et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. Invest Ophthalmol Vis Sci. 2007;48:839-848.
20. Keane PA, Liakopoulos S, Ongchin SC, et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:3115-3120.
21. Pons ME, Garcia-Valenzuela E. Redefining the limit of the outer retina in optical coherence tomography scans. Ophthalmology. 2005;112:1079-1085.
22. Costa RA, Calucci D, Skaf M, et al. Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci. 2004;45:2399-2406.
23. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol. 1999;127:688-693.
24. Otani T, Kishi S. Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema. Ophthalmology. 2007;114:104-107.
25. Yeung L, Lima VC, Garcia P, et al. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema. Ophthalmology. 2009;116:1158-1167.
26. Lattanzio R, Brancato R, Pierro L, et al. Macular thickness measured by optical coherence tomography (OCT) in diabeticpatients. Eur J Ophthalmol. 2002;12:482-487.
27. Sugimoto M, Sasoh M, Ido M, et al. Detection of early diabetic change with optical coherence tomography in type 2 diabetesmellitus patients without retinopathy. Ophthalmologica. 2005;219:379-385.
28. Fritsche P, van der Heijde R, Suttorp-Schulten MS, Polak BC.Retinal thickness analysis(RTA): an objective method to assess and quantify the retinal thickness in healthy controls and in diabetics without diabetic retinopathy. Retina. 2002;22:768-771.
29. Nilsson M, von Wendt G, Wanger P, Martin L. Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography. Br J Ophthalmol. 2007;91:1596-1598.
30. Verma A, Rani PK, Raman R, et al. Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (SD-OCT) study in individuals with diabetes, but no diabetic retinopathy. Eye (Lond). 2009;23:1824-1830.
31. van Dijk HW, Verbraak FD, Stehouwer M, et al. Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res. 2011;51:224-228.
32. van Dijk HW, Verbraak FD, Kok PH, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2012;53:2715-2719.
33. Bressler NM, Edwards AR, Antoszyk AN, et al. Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol. 2008;145:894-901.
34. Kashani AH, Zimmer-Galler IE, Shah SM, et al. Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol. 2010;149:496-502.
35. Sugimoto M, Sasoh M, Ido M, et al. Retinal nerve fiber layer decrease during glycemic control in type 2 diabetes [published online ahead of print August 8, 2010]. J Ophthalmol. doi:10.1155/2010/569215.
36. Verma A, Raman R, Vaitheeswaran K, et al. Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res. 2012;47:202-207.
37. Shahidi AM, Sampson GP, Pritchard N, et al. Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy. Diabet Med. 2012;29:e106-e111.
38. Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol. 1992;99:177-197.
39. Esmaeelpour M, Povazay B, Hermann B, et al. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:5311-5316.
40. Esmaeelpour M, Brunner S, Ansari-Shahrezaei S, et al. Choroidal thinning in diabetes type 1 detected by 3-dimensional 1060 nm optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:6803-6809.
41. Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci. 2012;53:6017-6024.
42. Regatieri CV, Branchini L, Carmody J, et al. Choroidal thickness in patients with diabetic retinopathy analyzed by spectraldomain optical coherence tomography. Retina. 2012;32:563-568.
43. Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology. 1985;92:512-522.
44. McLeod DS, Lutty GA. High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci. 1994;35:3799-3811.
45. Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88:1060-1063.
46. Schocket LS, Brucker AJ, Niknam RM, et al. Foveolar choroidal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol. 2004;25:89-94.
47. Sogawa K, Nagaoka T, Takahashi A, et al. Relationship between choroidal thickness and choroidal circulation in healthy young subjects. Am J Ophthalmol. 2012;153:1129-1132.e1.
48. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144-168.
49. Poukens V, Glasgow BJ, Demer JL. Nonvascular contractile cells in sclera and choroid of humans and monkeys. Invest Ophthalmol Vis Sci. 1998;39:1765-1774.
50. Sim DA, Keane PA, Zarranz-Ventura J, et al. Predictive factors for the progression of diabetic macular ischemia. Am J Ophthalmol. 2013;156:684-692.